Brief: Nexalin Technology Reports Results Of Clinical Study In Treating Migraine Headaches And Related Symptoms

Nexalin Technology

07/08/2023 16:21

Aug 7 (Reuters) - Nexalin Technology Inc  NXL.O :
    * NEXALIN TECHNOLOGY REPORTS RESULTS OF CLINICAL STUDY
SUPPORTING
THE THERAPEUTIC BENEFITS OF ITS GEN-2, 15 MILLIAMP
NEUROSTIMULATION DEVICE IN TREATING MIGRAINE HEADACHES AND
RELATED SYMPTOMS
    * NEXALIN TECHNOLOGY - STATISTICALLY SIGNIFICANT IMPROVEMENT
ACHIEVED IN ALL KEY METRICS OF STUDY OF GEN-2 15 MILLIAMP DEVICE
    * NEXALIN TECHNOLOGY INC- NO ADVERSE EVENTS WERE OBSERVED
DURING
TREATMENT IN TWO GROUPS OF STUDY

Source text for Eikon:  ID:nGNE4DR7px 
Further company coverage:  NXL.O